Semaglutide vs. Tirzepatide: Are We Closing the Gap?
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Semaglutide vs. Tirzepatide: Are We Closing the Gap?
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
How the STEP-UP trial came to life, and what made the 7.2mg dose possible
What the data actually says about weight loss and side effects at higher doses
Why trial design, pharmacokinetics, and estimands matter more than you think
What’s coming next in obesity meds: duals, triples, and even antagonists
The real talk on intermittent fasting, access issues, and preaching vs. science
Sign up for Dr. Spencer''s Clinic
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Pas encore de commentaire